trial · primary record
Tozorakimab
Viral Lung Infection and Acute Respiratory Failure
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 3527 |
| Primary completion | 2027-11-04 |
| Primary endpoint | Proportion of participants who die or progress to Invasive Mechanical Ventilation (IMV) / Extracorporeal Membrane Oxygen (ECMO) |
| Registry ID | NCT05624450 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:45:17.277Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05624450
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Tozorakimab · compound